TLP
BNTX icon

Tri Locum Partners’s BioNTech BNTX Stock Holding History

Tri Locum Partners’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-39,663
Closed -$5.91M – 49
2022
Q2 		$5.91M Buy
39,663
+8,740
+28% +$1.34M 2.42% 16
2022
Q1 		$5.27M Buy
+30,923
New +$5.2M 2.06% 24
2021
Q4 		– Sell
-5,506
Closed -$1.5M – 44
2021
Q3 		$1.5M Buy
+5,506
New +$1.75M 0.6% 24

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Tri Locum Partners's BNTX Position: Q3 2022 in Review

Tri Locum Partners sold out of BioNTech (BNTX) in Q3 2022, closing a stake of 39,663 shares — an estimated $5.91M sold.

Tri Locum Partners first reported a position in BNTX in Q3 2021 and held it in 3 quarters. The position peaked at $5.91M in Q2 2022. 264 funds tracked by Wall St. Rank hold BNTX as of Q3 2022.

  • Tri Locum Partners reported no remaining BioNTech position as of Q3 2022 after selling out during the quarter.
  • Tri Locum Partners sold 39,663 BioNTech shares in Q3 2022, an estimated $5.91M.
  • Tri Locum Partners first reported a position in BioNTech in Q3 2021 and held it in 3 quarters.
  • Tri Locum Partners's BioNTech position peaked at $5.91M in Q2 2022.
  • 264 funds tracked by Wall St. Rank held BioNTech as of Q3 2022.

Based on Tri Locum Partners's 13F filing for Q3 2022, filed 14 Nov 2022.